Why INOVIQ (ASX:IIQ) chief executive Dr Leearne Hinch will step down on 27 October as the chair moves into an interim executive role

Sonal Goyal

23 October 2026 05:58 PM AEDT

Why INOVIQ (ASX:IIQ) chief executive Dr Leearne Hinch will step down on 27 October as the chair moves into an interim executive role

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

INOVIQ announced that Dr Leearne Hinch will step down as chief executive officer on 27 October 2026 by mutual agreement with the board.
Chairman Peter Gunzburg will become executive chair on an interim basis, with no additional remuneration.
The company is conducting an executive search and will outline future plans at its Annual General Meeting on 25 November 2026.

INOVIQ Ltd (ASX:IIQ) announced on 23 October 2026 that Dr Leearne Hinch will step down as chief executive officer on 27 October 2026. The company said the change was mutually agreed between the board and Dr Hinch. Chairman Peter Gunzburg will become executive chair on an interim basis from that date.

Under the interim arrangement, Mr Gunzburg will take on executive responsibilities in addition to his chair role. The company stated that he will receive no additional remuneration for doing so. INOVIQ said it is conducting an executive search for a new chief executive and will announce an appointment in due course. It did not give a date.

The announcement does not disclose the terms of Dr Hinch's departure, including any payments or notice arrangements, and it gives no reason for the change beyond the statement that it was mutually agreed.

Track record cited by the board

The board credited Dr Hinch with about a decade of contribution to the company. According to INOVIQ (ASX:IIQ), under her Leadership the Business moved from a single early-stage technology to a portfolio of two products on the market, two in later-stage development and one in early development. These descriptions are the company's own and the announcement does not provide revenue, sales or clinical data.

What the company has said about strategy

INOVIQ said it has recently completed a review and will outline its future plans at its annual general meeting on 25 November 2026. The announcement gives no detail of the review's findings or of any intended changes to the product portfolio, cost base or funding.

Leadership arrangements

Until a permanent appointment is made, Mr Gunzburg combines the roles of chair and executive leader, which the company has described as an interim measure only.

Confirmed dates

Dr Hinch's last day as chief executive is 27 October 2026, and the annual general meeting is scheduled for 25 November 2026. No date has been given for the new chief executive's appointment.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.